CIPLA
|
The Current P/B Ratio of CIPLA is 4.04.
Share Price | ₹1,554.2 | Jul 31,2025 |
Market Cap | ₹125,548.3 Cr | |
Book Value | ₹31,079.3 Cr | Mar2025 - Consolidated Results |
Price/Book | 4.04x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of CIPLA
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹125,548.3 Cr] as on Jul 31,2025
(/) Book Value [ ₹31,079.3 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 4.04x ]
Thus, for CIPLA , the investors are currently willing to pay '4.04 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of CIPLA !
The chart below summarizes the trend in P/B Ratio of CIPLA over the last five years.
Historical PB (Price/Book ) ratio chart of CIPLA
PB Ratio Performance Analysis for CIPLA
- CIPLA 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.79x.
- CIPLA 's operated at median p/b ratio of 3.75x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/b ratio peaked in Mar2024 at 4.53x.
- CIPLA 's p/b ratio hit its five-year low in Mar2023 of 3.11x.
How does CIPLA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
CIPLA | 31,079.30 | 4.04 | 125,548.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.67 | 409,219.0 |
DIVIS LABORATORIES LTD | 14,969.00 | 11.71 | 175,227.0 |
TORRENT PHARMACEUTICALS LTD | 7,590.69 | 16.68 | 126,643.0 |
DR REDDYS LABORATORIES LTD | 33,404.90 | 3.18 | 106,063.0 |
MANKIND PHARMA LTD | 14,288.70 | 7.42 | 105,978.0 |
ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.07 | 97,604.7 |
LUPIN LTD | 17,119.50 | 5.15 | 88,097.4 |
AUROBINDO PHARMA LTD | 32,653.30 | 2.03 | 66,266.6 |
ABBOTT INDIA LTD | 4,204.27 | 17.40 | 73,145.6 |
ALKEM LABORATORIES LTD | 11,948.70 | 5.03 | 60,160.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs CIPLA 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.03x |
Max industry PB | 17.40x |
Median industry PB | 5.15x |
Average industry PB | 7.49x |
You may also like the below Video Courses